Pharmaceuticals in Singapore

Pharmaceuticals in Singapore


  • Products Id :- OHMF4312
  • |
  • Pages: 42
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Pharmaceuticals in Singapore

Summary

Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Singapore pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Singaporean pharmaceuticals market had total revenues of USD 0.9bn in 2017, representing a compound annual growth rate (CAGR) of 4.6% between 2013 and 2017.

- Growth is bolstered by an ageing population; meaning there will be a higher demand for drugs for conditions linked to ageing such as arthritis, dementia and respiratory diseases.

- Growth in the Singaporean pharmaceuticals market has helped the city-state become a regional hub for the manufacturing, research and development for multinational pharmaceutical companies

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Singapore

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Singapore pharmaceuticals market by value in 2017?

- What will be the size of the Singapore pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the Singapore pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in Singapore's pharmaceuticals market?



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 16

New entrants 18

Threat of substitutes 20

Degree of rivalry 21

Leading Companies 23

Astellas Pharma Inc. 23

GlaxoSmithKline Plc 26

Novartis AG 30

Pfizer Inc. 33

Macroeconomic Indicators 37

Country data 37

Methodology 39

Industry associations 40

Related MarketLine research 40

Appendix 41

About MarketLine 41

List of Figures

Figure 1: Singapore pharmaceuticals market value: USD billion, 2013-17

Figure 2: Singapore pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: Singapore pharmaceuticals market share: % share, by value, 2017

Figure 4: Singapore pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in Singapore, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in Singapore, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in Singapore, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2017

Figure 11: Astellas Pharma Inc.: revenues & profitability

Figure 12: Astellas Pharma Inc.: assets & liabilities

Figure 13: GlaxoSmithKline Plc: revenues & profitability

Figure 14: GlaxoSmithKline Plc: assets & liabilities

Figure 15: Novartis AG: revenues & profitability

Figure 16: Novartis AG: assets & liabilities

Figure 17: Pfizer Inc.: revenues & profitability

Figure 18: Pfizer Inc.: assets & liabilities

List of Tables

Table 1: Singapore pharmaceuticals market value: USD billion, 2013-17

Table 2: Singapore pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: Singapore pharmaceuticals market share: % share, by value, 2017

Table 4: Singapore pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: Astellas Pharma Inc.: key facts

Table 6: Astellas Pharma Inc.: key financials (USD )

Table 7: Astellas Pharma Inc.: key financials (JPY)

Table 8: Astellas Pharma Inc.: key financial ratios

Table 9: GlaxoSmithKline Plc: key facts

Table 10: GlaxoSmithKline Plc: key financials (USD )

Table 11: GlaxoSmithKline Plc: key financials (GBP)

Table 12: GlaxoSmithKline Plc: key financial ratios

Table 13: Novartis AG: key facts

Table 14: Novartis AG: key financials (USD )

Table 15: Novartis AG: key financial ratios

Table 16: Pfizer Inc.: key facts

Table 17: Pfizer Inc.: key financials (USD )

Table 18: Pfizer Inc.: key financial ratios

Table 19: Singapore size of population (million), 2013-17

Table 20: Singapore gdp (constant 2005 prices, USD billion), 2013-17

Table 21: Singapore gdp (current prices, USD billion), 2013-17

Table 22: Singapore inflation, 2013-17

Table 23: Singapore consumer price index (absolute), 2013-17

Table 24: Singapore exchange rate, 2013-17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license
Single User License
USD 350 INR 25144
Site License
USD 700 INR 50288
Corporate User License
USD 1050 INR 75432

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com